Columnar is a biotechnology company focused on developing advanced precision medical interventions. They utilize structural biology, computational intelligence, and neural engineering to create novel therapeutics, with a particular emphasis on expanding the utility of spinal cord stimulation. The company is currently in the clinical development stage, working towards regulatory approval for its products.